Guggenheim Capital’s Assembly Biosciences ASMB Stock Holding History

Guggenheim Capital’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-176	Closed	-$14K	–	3204
2014 Q1	$14K	Buy	+176	New	+$27.4K	﹤0.01%	3251

Other funds holding ASMB

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Guggenheim Capital's ASMB Position: Q2 2014 in Review

Guggenheim Capital sold out of Assembly Biosciences (ASMB) in Q2 2014, closing a stake of 176 shares — an estimated $14K sold.

Guggenheim Capital first reported a position in ASMB in Q1 2014 and held it in 1 quarter. The position peaked at $14K in Q1 2014. 27 funds tracked by Wall St. Rank hold ASMB as of Q2 2014.

Guggenheim Capital reported no remaining Assembly Biosciences position as of Q2 2014 after selling out during the quarter.
Guggenheim Capital sold 176 Assembly Biosciences shares in Q2 2014, an estimated $14K.
Guggenheim Capital first reported a position in Assembly Biosciences in Q1 2014 and held it in 1 quarter.
Guggenheim Capital's Assembly Biosciences position peaked at $14K in Q1 2014.
27 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2014.

Based on Guggenheim Capital's 13F filing for Q2 2014, filed 14 Aug 2014.